会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • USE FOR CD45+ CELLS OR A CD45+ CELL CULTURE FLUID FOR PROMOTING THE GROWTH OF MESENCHYMAL STEM CELLS
    • 用于CD45 +细胞或CD45 +细胞培养液以促进间质干细胞的生长
    • WO2009120043A3
    • 2009-12-30
    • PCT/KR2009001581
    • 2009-03-27
    • UNIV KYUNG HEE UNIV IND COOP GROUPSON YOUNG SOOKHONG HYUN SOOKAHN WOO SUNG
    • SON YOUNG SOOKHONG HYUN SOOKAHN WOO SUNG
    • C12N5/02C07K14/715C12N9/12
    • C12N5/0663C12N5/0665C12N2502/1157
    • The present invention relates to a use for CD45+ cells or a CD45+ cell culture fluid for promoting the growth of mesenchymal stem cells; a composition for promoting the growth of mesenchymal stem cells comprising CD45+ cells or a CD45+ cell culture fluid; and a culturing method for promoting the growth of mesenchymal stem cells by adding CD45+ cells or a CD45+ cell culture fluid to mesenchymal stem cells and allowing culturing to proceed. If culturing is carried out by adding CD45+ cells or a CD45+ cell culture fluid to mesenchymal stem cells, then the colony-forming ability of the mesenchymal stem cells is increased by at least three times as compared with culturing of mesenchymal stem cells alone. Moreover, CD29+ cells which have been cultured with treatment by CD45+ cells or a CD45+ cell culture fluid maintain, unchanged, the morphological characteristics of mesenchymal stem cells, cell markers, and inherent characteristics such as pluripotency. Thus CD45+ cells or a CD45+ cell culture fluid can be used to promote the growth of mesenchymal stem cells, and a culturing method in which CD45+ cells or a CD45+ cell culture fluid is added to mesenchymal stem cells and culturing is allowed to proceed can be used to grow mesenchymal stem cells in sufficient number to allow them to be used in cell therapy.
    • 本发明涉及用于促进间充质干细胞生长的CD45 +细胞或CD45 +细胞培养液的用途; 用于促进包含CD45 +细胞或CD45 +细胞培养液的间充质干细胞生长的组合物; 以及通过将CD45 +细胞或CD45 +细胞培养液添加至间充质干细胞并允许进行培养来促进间充质干细胞生长的培养方法。 如果通过将CD45 +细胞或CD45 +细胞培养液添加到间充质干细胞中进行培养,则与单独培养间充质干细胞相比,间充质干细胞的集落形成能力增加至少三倍。 此外,通过CD45 +细胞或CD45 +细胞培养液处理而培养的CD29 +细胞维持间充质干细胞的形态特征,细胞标记和多能性等固有特征不变。 因此可以使用CD45 +细胞或CD45 +细胞培养液来促进间充质干细胞的生长,并且可以使用将CD45 +细胞或CD45 +细胞培养液添加至间充质干细胞并允许进行培养的培养方法 以充足的数量培养间充质干细胞以允许它们用于细胞治疗。
    • 6. 发明申请
    • AGENT FOR STIMULATING MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS
    • 促进内皮祖细胞移植的促进剂
    • WO2011019221A2
    • 2011-02-17
    • PCT/KR2010/005307
    • 2010-08-12
    • CELL & BIO CO., LTD.SON, Young SookHONG, Hyun Sook
    • SON, Young SookHONG, Hyun Sook
    • A61K38/08A61P9/10
    • A61K38/046
    • The present invention provides a composition for stimulating the mobilization of endothelial precursor cells, which comprises subs tance-P (SP). Substance-P accordingto the invention exhibits an activity of stimulating the mobilization of endothelial precursor cells from the bone marrow, thereby stimulating vasculogenesis. Thus, substance-P exhibits excellent effects on the prevention or treatment of diseases, including myocardial infarction, angina, ischemic stroke, cerebrovascular dementia, cerebral infarction, sequelae of cerebral injury, spinal cord injury, sequelae of spinal nerve injury, degenerative diseases, sequelae of cerebral infarction, peripheral nerve disorders, presbyopia, degenerative hearing loss, sequelae of brain surgery, and diabetic ulcer, which are accompanied by ischemic vascular injury or traumatic vascular injury.
    • 本发明提供了用于刺激内皮前体细胞动员的组合物,其包含基础-P(SP)。 根据本发明的物质-P表现出刺激来自骨髓的内皮前体细胞的动员,从而刺激血管发生的活性。 因此,P物质在预防或治疗疾病包括心肌梗塞,心绞痛,缺血性中风,脑血管性痴呆,脑梗塞,脑损伤后遗症,脊髓损伤,脊髓神经损伤后遗症,退行性疾病,后遗症 伴有缺血性血管损伤或创伤性血管损伤的脑梗塞,周围神经障碍,老花,退行性听力丧失,脑外科手术后遗症和糖尿病性溃疡。
    • 8. 发明申请
    • AGENT FOR STIMULATING MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS
    • 刺激内源性原核细胞动员的药剂
    • WO2011019221A3
    • 2011-05-26
    • PCT/KR2010005307
    • 2010-08-12
    • CELL & BIO CO LTDSON YOUNG SOOKHONG HYUN SOOK
    • SON YOUNG SOOKHONG HYUN SOOK
    • A61K38/08A61P9/10
    • A61K38/046
    • The present invention provides a composition for stimulating the mobilization of endothelial precursor cells, which comprises subs tance-P (SP). Substance-P accordingto the invention exhibits an activity of stimulating the mobilization of endothelial precursor cells from the bone marrow, thereby stimulating vasculogenesis. Thus, substance-P exhibits excellent effects on the prevention or treatment of diseases, including myocardial infarction, angina, ischemic stroke, cerebrovascular dementia, cerebral infarction, sequelae of cerebral injury, spinal cord injury, sequelae of spinal nerve injury, degenerative diseases, sequelae of cerebral infarction, peripheral nerve disorders, presbyopia, degenerative hearing loss, sequelae of brain surgery, and diabetic ulcer, which are accompanied by ischemic vascular injury or traumatic vascular injury.
    • 本发明提供了一种用于刺激内皮前体细胞动员的组合物,其包括临界-P(SP)。 根据本发明的物质-P表现出刺激内皮前体细胞从骨髓的动员,从而刺激血管发生的活性。 因此,物质-P对预防或治疗包括心肌梗死,心绞痛,缺血性中风,脑血管性痴呆,脑梗塞,脑损伤后遗症,脊髓损伤,脊髓神经损伤后遗症,退行性疾病,后遗症等疾病的预防或治疗具有优异的效果 的脑梗塞,周围神经障碍,老花眼,退行性听力损失,脑外科后遗症和糖尿病性溃疡,伴有缺血性血管损伤或创伤性血管损伤。
    • 9. 发明申请
    • A COMPOSITION FOR TREATING DAMAGE OF CENTRAL OR PERIPHERAL NERVE SYSTEM
    • 用于治疗中央或外周神经系统损伤的组合物
    • WO2007091790A1
    • 2007-08-16
    • PCT/KR2007/000316
    • 2007-01-19
    • KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCESUNIVERSITY-INDUSTRY COOPERATION GROUPE OF KYUNGHEE UNIVERSITYSON, Young-SookCHI, Guang-FanKIM, Mi-Ra
    • SON, Young-SookCHI, Guang-FanKIM, Mi-Ra
    • A61K35/30C12N5/06
    • C12N5/0622A61K35/30C12N2501/115C12N2501/135C12N2501/195C12N2501/385
    • The present invention provides a composition for treating damage of central or peripheral nerve system comprising neural precursor cell derived from subcutaneous tissue; neuron obtained by differentiating the neural precursor cell; or oligodendrocyte or Schwann cell obtained by differentiating the neural precursor cell; a use of neural precursor cell derived from subcutaneous tissue, neuron obtained by differentiating the neural precursor cell, or oligodendrocyte or Schwann cell obtained by differentiating the neural precursor cell, for the manufacture of an agent for treating damage of central or peripheral nerve system; a method for treating damage of central or peripheral nerve system which comprises administrating to a mammal a therapeutically effective amount of neural precursor cell derived from subcutaneous tissue, neurons obtained by differentiating the neural precursor cell, or oligodendrocyte or Schwann cell obtained by differentiating the neural precursor cell. Further, the present invention provides a method of preparing the neural precursor cell, neurons, oligodendrocyte or Schwann cell of the present invention.
    • 本发明提供一种用于治疗包含来自皮下组织的神经前体细胞的中枢或周围神经系统的损伤的组合物; 通过分化神经前体细胞获得的神经元; 或通过分化神经前体细胞获得的少突胶质细胞或雪旺氏细胞; 使用衍生自皮下组织的神经前体细胞,通过分化神经前体细胞获得的神经元,或通过分化神经前体细胞获得的少突胶质细胞或施旺细胞,用于制造用于治疗中枢或周围神经系统损伤的药剂; 用于治疗中枢或周围神经系统的损伤的方法,其包括向哺乳动物施用治疗有效量的来自皮下组织的神经前体细胞,通过分化神经前体细胞获得的神经元,或通过分化神经前体获得的少突胶质细胞或施万细胞 细胞。 此外,本发明提供了制备本发明的神经前体细胞,神经元,少突胶质细胞或雪旺氏细胞的方法。